Interest of the Addition of Docetaxel to Standard Treatment in First-line Advanced HER2 Positive Gastroesophageal Adenocarcinoma in Selective Patients
Clinical trial NCT04920747 · COMPLETED
Trial details
- NCT number
- NCT04920747
- Sponsor
- Centre Hospitalier Universitaire de Besancon
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-04-01
- Primary completion
- 2021-05-31
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.